GSZ 2013 - Conference



Moderation: R. Zweigert, Franz
1) A. Limpert, Lübeck Approach to sensitize glioma stem cells to standard chemotherapy
2) D. Reichert, Dresden Are murine mesenchymal stromal cells a trap for human hematopoietic stem and progenitor cells?
3) EC. Buss, Heidelberg/ Rehovot, Israel Mechanisms of mobilization of human primary precursor-B-ALL cells in an in vivo model system by the CXCR4-antagonist AMD3100 and by catecholamines
4) V. Lepperhof, Köln Bioluminescence in vivo imaging of genetically selected iPS cell-derived cardiomyocytes after transplantation into infarcted heart
5) S. Ulrich, Hannover Differentiation of human pluripotent stem cells into lung epithelial cells
6) F. Schlegel, Leipzig A new possibility to reprogram bone marrow stem cells into endothelial like cells
7) M. Schweinlin, Würzburg In vitro differentiation of murine embryonic stem cells into intestinal cells


Moderation: t.b.a.
8) CO. Heras, Köln A bioengineered matrix with physiological elasticity facilitates long-term culture of pluripotent stem cell-derived cardiomyocytes
9) Narges-Zare Mehrjardi, Köln/Tehran, Iran Genetic manipulation of neural progenitor cells derived from human induced pluripotent stem cells by using zinc finger nucleases
10) R. Zweigert, Hannover Generation of endothelial cells from scalable cultures of undifferentiated human pluripotent stem cells
11) A. Witthuhn, Langen Line1-mediated retrotransposition in human pluripotent stem cells: consequences for genomic stability of HES and HIPS cells and their derivatives
12) K. Osetek, Hannover Young versus aged cell sources - genetic aberrations in iPS cells and the effect of primary cell proliferation on reprogramming efficiency
13) L. Gan and B. Denecke, Aachen Transcription factors, microRNAs and their interactions during cardiomyocyte-specific differentiation of murine embrionic stem cells
14) I. Gruh, Hannover Optogenetic control of stem cell-derived bioartificial cardiac tissue
15) K. Burkert, Köln Monitoring differentiation of pluripotent stem cells to cardiomyocytes by measuring cardiac Troponin T release into the cell culture medium